CRHM - CRH Medical Corporation

NYSE American - NYSE American Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
213.95M
Enterprise Value 3
324.52M
Trailing P/E
51.72
Forward P/E 1
50.00
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
1.75
Price/Book (mrq)
2.86
Enterprise Value/Revenue 3
2.66
Enterprise Value/EBITDA 6
6.07

Trading Information

Stock Price History

Beta (3Y Monthly) 1.36
52-Week Change 30.66%
S&P500 52-Week Change 318.11%
52 Week High 33.7900
52 Week Low 30.0000
50-Day Moving Average 33.0525
200-Day Moving Average 32.9608

Share Statistics

Avg Vol (3 month) 330.91k
Avg Vol (10 day) 346.97k
Shares Outstanding 571.52M
Float 58.01M
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short (Oct 31, 2019) 431.7k
Short Ratio (Oct 31, 2019) 41.65
Short % of Float (Oct 31, 2019) 40.04%
Short % of Shares Outstanding (Oct 31, 2019) 40.04%
Shares Short (prior month Sep 30, 2019) 449.53k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 3.49%
Operating Margin (ttm)15.72%

Management Effectiveness

Return on Assets (ttm)5.87%
Return on Equity (ttm)8.23%

Income Statement

Revenue (ttm)122.04M
Revenue Per Share (ttm)1.68
Quarterly Revenue Growth (yoy)5.90%
Gross Profit (ttm)26.75M
EBITDA 53.49M
Net Income Avi to Common (ttm)4.26M
Diluted EPS (ttm)0.0580
Quarterly Earnings Growth (yoy)268.20%

Balance Sheet

Total Cash (mrq)5.22M
Total Cash Per Share (mrq)0.07
Total Debt (mrq)68.42M
Total Debt/Equity (mrq)57.85
Current Ratio (mrq)2.83
Book Value Per Share (mrq)1.05

Cash Flow Statement

Operating Cash Flow (ttm)43.81M
Levered Free Cash Flow (ttm)41.57M